Keystone experts are thought leaders in their fields and are prolific writers on their findings. The experts create leading analytical frameworks for evaluating ecosystem strategy, innovation processes, IP evaluation, antitrust analysis and more. The research of our experts provides Keystone with unique access to large, cross-sectional studies of industry players from which we develop the best practices of corporate strategy, alliances, sales, marketing, and product development. Please contact us to learn more about our experts' research.

Below are select recent Books.

One Strategy: Organization, Planning, and Decision Making By Steven Sinofsky and Marco Iansiti; Wiley Press, 2009 One Strategy analyzes how a management team tweaked and optimized the fine line between strategy and execution in developing the next generation of a major product, detailed in a series of internal blogs by Microsoft Windows Division President Steven Sinofsky and merged with insightful context from technology and operations strategy expert Marco Iansiti. Along the way, One Strategy examines the concepts, capabilities, processes, and behaviors to align around one strategy and deliver impact – thus developing Strategic Integrity. All about developing and executing great, innovative strategies, One Strategy reveals how you can build the right organizational capabilities and base of understanding, generate insightful strategies, develop detailed plans, and lead your corporate strategies to completion.

Science Business: The Promise, the Reality, and the Future of Biotech by Gary P. Pisano; Harvard Business School Press, 2006 In Science Business, Professor Pisano analyzes why the biotechnology industry failed to perform up to expectations despite all its promises. Professor Pisano’s unique critique of the industry reveals the underlying causes of biotech’s problems and offers an overall analysis on how the industry works. According to Pisano, the biotech industry’s faces three unique business challenges: 1) the financing of high risk R&D investments in uncertain and long time horizons, 2) rapid learning to keep pace with advances in drug science knowledge, and 3) integration of capabilities across a broad spectrum of scientific and technological knowledge bases. He prescribes an approach to fixing the industry which includes new business models, modified organizational structures, and financing arrangements that place greater emphasis on integration and long-term learning over shorter-term “monetization” of intellectual property.

The Keystone Advantage: What the New Dynamics of Business Ecosystems Mean for Strategy, Innovation, and Sustainability by Marco Iansiti and Roy Levien; Harvard Business School Press, 2004 In biological ecosystems, "keystone" species maintain the healthy functioning of the entire system because their own survival depends on it. In the Keystone Advantage, Marco Iansiti and Roy Levien argue that business ecosystems work in much the same way--one company's success depends on the success of its partners. Based on more than 10 years of research and practical experience within industries from retail to automotive to software, The Keystone Advantage outlines a framework that goes beyond maximizing internal competencies to leveraging the collective competencies of one's entire network for competitive advantage.

Design-Driven Innovation: How to Compete by Radically Innovating the Meaning of Products by Roberto Verganti; Harvard Business School Publishing, 2009 Until now, the literature on innovation has focused either on radical innovation pushed by technology or incremental innovation pulled by the market. In this book, Roberto Verganti introduces a radical shift in perspective that introduces a bold new way of competing – it's about having a vision, and taking that vision to the customers. Design-driven innovations do not come from the market; they create new markets. They don't push new technologies; they push new meanings. With detailed examples from leading European and American companies, Verganti outlines that for truly breakthrough products and services, we must look beyond customers and users to those experts ("interpreters") who deeply understand and shape the markets they work in.

Intellectual Property Damages: Guidelines and Analysis by Mark Glick, Lara Reymann, and Richard Hoffman, 2002 Intellectual Property Damages presents the basics of intellectual property, the litigation process, the essential "rules" in postulating damages theories, the economic principles that are the foundation for much of IP damages, and the skills necessary to correctly calculate damages in IP cases. Intellectual Property Damages contains case summaries, useful forms for discovery, examples of effective expert opinions and testimony, and detailed calculations under various theories of damages. It also incorporates graphs illustrating economic principles, equations that might be used to support (or detract from) a damages theory, and examples of legal documents that commonly appear in IP litigation. Glick’s knowledge is built upon experience with law, economics, accounting, and (to a more limited extent) finance in the context of IP damages theories.